NBSE NeuBase Therapeutics, Inc. | 1173281
Available Fillings
Total Fillings:664
| Form Type | Form Count |
|---|---|
| 8-K | 197 |
| UPLOAD | 25 |
| NT 10-K | 10 |
| NT 10-Q | 11 |
| 10QSB | 16 |
| 10QSB/A | 5 |
| SB-2 | 1 |
| 10-Q | 47 |
| CORRESP | 24 |
| S-3/A | 2 |
| 8-A12B | 1 |
| S-8 | 5 |
| CT ORDER | 2 |
| 10KSB/A | 1 |
| SC 13D/A | 3 |
| 3/A | 1 |
| SC 13D | 3 |
| 425 | 9 |
| POS AM | 2 |
| SC 13G | 13 |
| 8-K/A | 12 |
| S-4 | 1 |
| 15-12G | 1 |
| 5 | 2 |
| 10-K | 15 |
| S-3MEF | 1 |
| 10KSB | 5 |
| SB-2/A | 8 |
| ARS | 1 |
| 4/A | 2 |
| DEFA14A | 10 |
| SC 13G/A | 13 |
| 25-NSE | 1 |
| 424B3 | 6 |
| 424B5 | 14 |
| REGDEX/A | 1 |
| DEF 14A | 11 |
| 4 | 110 |
| 3 | 22 |
| 10-Q/A | 6 |
| EFFECT | 8 |
| 10-K/A | 6 |
| S-1 | 1 |
| 10-QT | 1 |
| S-4/A | 4 |
| S-8 POS | 5 |
| PRE 14A | 4 |
| S-3 | 6 |
| D | 7 |
| CERTNAS | 1 |
| SC 14F1 | 1 |
Financials
Total:283
Ipos
Total:56
Insider transactions
Total:137
Institutional filings
Total:27
Merger acquisition
Total:207
Proxy filings
Total:15